Eli Lilly (LLY) ACCELERATE Trial Proves 'Modestly Positive' for Esperion Therapeutics (ESPR) LDL Hypothesis - Stifel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to Eli Lilly (LLY) ACCELERATE Trial Proves 'Modestly Positive' for Esperion Therapeutics (ESPR) LDL Hypothesis - Stifel
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.16 --0 (-0%)
Previous Close $3.16    52 Week High $30.41 
Open $3.16    52 Week Low $9.40 
Day High $3.17    P/E N/A 
Day Low $3.15    EPS $-21.87 
Volume 4,628,574       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1104.70 +2.62 (0.24%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 255.72 
Day Low $1079.22    EPS $4.32 
Volume 1,487,087